Drugs / V120083
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03028870 | Mar → Nov 2017 | osteoarthritis, knee | Purdue Pharma LP | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V120083 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03028870 ↗ |
| Route | Oral | “V120083 30-mg capsules taken orally twice daily” NCT03028870 ↗ |